Trypanosoma cruzi: Effects of adrenalectomy during the acute phase of experimental infection

Experimental Parasitology

Volumn 120, Issue 1, 2008, Pages 10-14

  Guerra Lopes, Elaine S ^a   Caldeira, Jerri C ^b   Santos, Carla D ^c   Toldo, Míriam P A ^c   Faccioli, Lúcia H ^c   Sá Nunes, Anderson ^c   Albuquerque, Sérgio ^c   Prado Jr , José C ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adrenalectomy; Nitric oxide; Parasitemia; Peritoneal macrophages; Rats; Trypanosoma cruzi

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; NITRIC OXIDE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE SYSTEM; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ADRENALECTOMY; ANIMALS; CELL COUNT; CHAGAS DISEASE; HEART; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MALE; MICE; MYOCARDIUM; NITRIC OXIDE; PARASITEMIA; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; TRYPANOSOMA CRUZI;

EID: 48649103391     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.04.001     Document Type: Article

References (41)

1. Ayala A., Herdon C.D., Lehman D.L., DeMaso C.M., Ayala C.A., and Chaudry I.H. The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock 3 (1995) 259-267
2. Bertini R., Bianchi M., and Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. Journal of Experimental Medicine 167 (1988) 1708-1712
3. Besedovsky H.O., and Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocrinology Review 17 (1996) 64-102
4. Bishayi B., and Ghosh S. Metabolic and immunological responses associated with in vivo glucocorticoid depletion by adrenalectomy in mature Swiss albino rats. Life Sciences 73 (2003) 3159-3174
5. Brener Z. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4 (1962) 389-396
6. Brener Z., and Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. International Archives of Allergy and Immunology 114 (1997) 103-110
7. Brunet L.R. Review-nitric oxide in parasitic infections. International Immunopharmacology 1 (2001) 1457-1467
8. Clark I.A., and Rockett K.A. Nitric oxide and parasitic disease. Advances in Parasitology 37 (1996) 1-55
9. Castro M.A.P., and Brener Z. Estudo parasitológico e anátomo-patológico da fase aguda da doença de Chagas em cães inoculados com duas diferentes cepas do Trypanosoma cruzi. Revista da Sociedade Brasileira de Medicina Tropical 18 (1985) 233-239
10. Davies E., and MacKenzie S.M. Extra-adrenal production of corticosteroids. Clinical Experimental Pharmacology Physiology 30 (2003) 437-445
11. Fichera L.E., Albareda M.C., Laucella S.A., and Postan M. Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release. Infection and Immunity 72 (2004) 359-363
12. Fleshner M., Deak T., Nguyen K.T., Watkins L.R., and Maier S.F. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. Journal of Immunology 166 (2001) 3813-3819
13. Garcia S.B., Paula J.S., Giovannetti G.S., Zenha F., Ramalho E.M., Zucoloto S., Silva J.S., and Cunha F.Q. Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Experimental Parasitology 93 (1999) 191-197
14. Golden J.M., and Tarleton R.L. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Experimental Parasitology 72 (1991) 391-402
15. Leite de Moraes M.C., Hontebeyrie-Joskowicz M., Leboulenger F., Savino W., and Dardenne M. Studies on the thymus in Chagas' disease. II. Thymocyte subset fluctuations in Trypanosoma cruzi-infected mice: relationship to stress. Scandinavian Journal of Immunology 33 (1991) 267-275
16. Morales-Montor J., Mohamed F., and Damian R.T. Schistosoma mansoni: the effect of adrenalectomy on the murine model. Microbes and Infection 6 (2004) 475-480
17. Munõz Fernández M.A., Fernández M.A., and Fresno M. Synergism between tumor necrosis factor-α and interferon-g on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide dependent mechanism. European Journal of Immunology 22 (1992) 301-307
18. Nabors G.S., and Tarleton R.L. Differential control of IFN-γ and IL-2 production during Trypanosoma cruzi infection. Journal of Immunolology 146 (1991) 3591-3598
19. Oswald I.P., Wynn T.A., Sher A., and James S.L. NO as Na effector molecule of parasite killing: modulation of its synthesis by cytokines. Comparative Biochemistry Physiology 108 (1994) 11-18
20. Pérez A.R., Roggero E., Nicora A., Palazzi J., Besedovsky H.O., Del Rey A., and Bottasso O.A. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behavior Immunology 21 (2007) 890-900
21. Petray P.B., Rottenberg M.E., Bertot G., Corral R.S., Diaz A., Orn A., and Grinstein S. Effect of anti-interferon-γ and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunology Letters 35 (1993) 77-80
22. Petray P., Castaños-Velez E., Grinstein S., Örn A., and Rottenberg M.E. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunology Letters 47 (1995) 121-126
23. Radomski M.W., Palmer R.M., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 87 (1990) 10043-10047
24. Reed S.G. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. Journal of Immunology 140 (1988) 4342-4347
25. Rodrigues M.M., Ribeirão M., and Boscardin S.B. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunology Letters 73 (2000) 43-50
26. Roggero E., Pérez A.R., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Besedovsky H.O., Bottasso O.A., and Del Rey A. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. Journal of Endocrinology 190 (2006) 495-503
27. Rook G., Baker R., Walker B., Honour J., Jessop D., Hernandez-Pando R., Arriaga K., Shaw R., Zumla A., and Lightman S. Local regulation of glucocorticoid activity in sights of inflammation. In sights from the study of tuberculosis. American New York Academy of Science 917 (2000) 913-922
28. Saeftel M., Fleischer B., and Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infection and Immunity 69 (2001) 2252-2259
29. Sala M.A., Komesu M.C., Lopes R.A., and Maia Campos G. Karyometric study of basal cell carcinoma. Brazilian Dentist 5 (1994) 11-14
30. Santos C.D., Caldeira J.C., Toldo M.P., and Prado J.C. Trypanosoma cruzi: effects of repetitive stress during the development of experimental infection. Experimental Parasitology 110 (2005) 96-101
31. Santos C.D., Toldo M.P., and do Prado Junior J.C. Trypanosoma cruzi: the effects of dehydroepiandrosterone (DHEA) treatment during experimental infection. Acta Tropica 95 (2005) 109-115
32. Santos C.D., Toldo M.P., Levy A.M., Kawasse L.M., Zucoloto S., and do Prado Jr. J.C. Dehydroepiandrosterone affects Trypanosoma cruzi tissue parasite burdens in rats. Acta Tropica 102 (2007) 143-150
33. Santos C.D., Prado Jr. J.C., Toldo M.P., Levy A.M., Franci C.R., and Caldeira J.C. Trypanosoma cruzi: Plasma corticosterone after repetitive stress during the acute phase of infection. Experimental Parasitology 117 (2007) 405-410
34. Silva L.H.P., and Nussenszweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clinica Biologica 20 (1953) 191-208
35. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C.S., and Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and Immunity 63 (1995) 4862-4867
36. Torrico F., Heremans H., Rivera M.T., Van Marck E., Billiau A., and Carlier Y. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology 146 (1991) 3626-3632
37. Vespa G.N.R., Cunha F.Q., and Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infection and Immunity 62 (1994) 5177-5182
38. Yan S.M., Finato N., Di Loreto C., and Beltrami C.A. Nuclear size of myocardial cells in end-stage cardiomyopathies. Analytical and Quantitative Cytology and Histology 21 (1999) 174-180
39. WHO Technical Report Series n°811, 2002. Control of Chagas' disease. Geneve, WHO, p. 23.
40. Wiegers G.J., Stec I.E., Klinkert W.E., Linthorst A.C., and Reul J.M. Effect of glucocorticosteroids on microvascular permeability. American Review of Respiratory Disease 141 (1990) S39-S43
41. Williams T.J., and Yarwood H. Bidirectional effects of corticosterone on splenic T-cell activation: critical role of cell density and culture time. Neuroendocrinology 73 (2001) 139-148